Hämophilie-Behandlung in Österreich

Translated title of the contribution: Treatment of haemophilia in Austria

Christoph Male*, Cihan Ay, Richard Crevenna, Sabine Eichinger, Clemens Feistritzer, Robert Füller, Alexander Haushofer, Andreas Kurringer, Peter Neumeister, Stephan Puchner, Thomas Rettl, Thomas Schindl, Gerhard Schuster, Gerhard Schwarz, Michael Sohm, Werner Streif, Katharina Thom, Barbara Wagner, Eva Wissmann, Karl ZwiauerIngrid Pabinger

*Corresponding author for this work

Research output: Journal article (peer-reviewed)Journal article


This guideline is intended to provide practical guidance for the diagnosis and treatment of haemophilia in Austria. Few randomized controlled interventional trials are available addressing the treatment of haemophilia, therefore recommendations are usually based on low level of evidence and represent expert consensus.This guideline is based on the WFH guideline, published in 2020, and adapted according to the national circumstances and experience.It includes recommendations and suggestions for diagnosis and follow-up visits and pharmacological therapies for treatment and prophylaxis. Further topics comprise special aspects in children and adults with severe haemophilia, outcome measurement, and management of trauma, special bleedings and interventions, including dental procedures, inhibitors, management of haemophilia carriers, and psychosocial aspects.

Translated title of the contributionTreatment of haemophilia in Austria
Original languageGerman
Pages (from-to)75-102
Number of pages28
JournalWiener Klinische Wochenschrift. The Central European Journal of Medicine
Issue numberSuppl 4
Publication statusPublished - Jul 2024


Dive into the research topics of 'Treatment of haemophilia in Austria'. Together they form a unique fingerprint.

Cite this